Selling sickness: the pharmaceutical industry and disease mongering. - Wikidata - awgldk - TriplyDB

Selling sickness: the pharmaceutical industry and disease mongering.

Selling sickness: the pharmaceutical industry and disease mongering.

http://www.wikidata.org/entity/Q22242090

about

sameAs

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials The fight against disease mongering: generating knowledge for action.A propaganda index for reviewing problem framing in articles and manuscripts: an exploratory study Nosologomania: DSM & Karl Jaspers' critique of Kraepelin Prejudice and schizophrenia: a review of the 'mental illness is an illness like any other' approach Alosetron: a case study in regulatory capture, or a victory for patients' rights?Female genital mutilation: whose problem, whose solution?The marketing of a disease: female sexual dysfunction Lifestyle drugs: concept and impact on society Drugs for pre-osteoporosis: prevention or disease mongering?Why Most Clinical Research Is Not Useful Functional Somatic Syndromes: Emerging Biomedical Models and Traditional Chinese Medicine Is it ethical to use enhancement technologies to make us better than well?Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy Media, messages, and medication: strategies to reconcile what patients hear, what they want, and what they need from medications What are the public health effects of direct-to-consumer drug advertising?Disease mongering in drug promotion: do governments have a regulatory role?An agenda for research on adverse drug reactions Compliance of disease awareness campaigns in printed Dutch media with national and international regulatory guidelines The six most essential questions in psychiatric diagnosis: a pluralogue part 2: Issues of conservatism and pragmatism in psychiatric diagnosis Conflict of interest in online point-of-care clinical support websites: Table 1 Disease mongering and the fear of pandemic influenza.Medicine and Mind-Body Dualism: A Reply to Mehta's Critique.Evidence-based medicine: is it a bridge too far?Getting clearer on overdiagnosis.The role of medical language in changing public perceptions of illness Depression and anxiety as major determinants of neck pain: a cross-sectional study in general practice.Hormone replacement therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain.Advances in therapy for osteoporosis.The pharmaceutical industry and disease mongering. The industry works to develop drugs, not diseases.The making of a disease: female sexual dysfunction.The mistreatment of major depressive disorder.What is a disease?A prompt to the web: the media and health information seeking behaviour.Bipolar disorder: the shift to overdiagnosis.Drug policy down under: Australia's pharmaceutical benefits scheme.The devil in the details: public health and depression Perceived ambiguity about cancer prevention recommendations: associations with cancer-related perceptions and behaviours in a US population survey.Marketing disease: is osteoporosis an example of 'disease mongering'?Family medicine research: implications for Wonca.

P2860

Q21092367-DBA85944-C83E-4EFA-82D4-90FD305F32E0 Q21092387-8A93E226-5390-4B66-B268-6944ECFF9082 Q21135465-035B799E-8D02-4A33-8D91-25FD761A4689 Q21203530-113D01E4-2A02-4316-AD34-9DA04275BE4F Q22242335-3B6E1B0F-EBC2-4F32-9DCF-52FAECAD8214 Q24527220-19E0E941-EB39-4D49-A55B-5C45CCD42FE1 Q24550917-C463EC5F-D444-4042-ABC1-E5C9CD867099 Q24557503-EEEDD5E3-9CAC-47B9-8942-0A020760981E Q24617197-DF1422C8-F3D0-490A-9871-CE02F805BBC7 Q24649128-65ABF0E9-FB22-49DC-95E3-0359A16FB3B8 Q24707972-22C8869D-5DB9-4AC1-9561-339CC99D9D9D Q24799124-F163C802-9EF4-428B-B52D-E565F11856CB Q24809605-4E2239F6-828E-4E8A-9F8B-0519DDD139D7 Q26784106-981F2D3B-5609-4436-9956-CBB4C64F85EF Q27013553-1D57D36B-098F-42D3-85D0-5021CF58AA76 Q28195995-6194F85B-6DF1-4E07-8EE4-8663E9E18F88 Q28468759-C140CA94-18CA-4793-957D-A033C6A8809B Q28469318-2CBE94AC-C024-481E-9629-62EC7673B25F Q28542862-0BE77F6D-EE42-43C2-A294-BA8696B822EC Q28727530-8138693B-A996-4E43-B6B7-FEDFB2FEFB20 Q30040716-50578D3C-B64D-4B07-9464-ACA21CD7A686 Q30226736-2ECC3056-648B-4E63-B38C-1D5D40E4F018 Q30363199-C49F38A1-C597-407A-9968-1E745E487DAC Q30381145-BAC97160-9224-48D1-9368-1A9294CAE1EB Q30387719-AEA38DDD-E79A-43CB-B80F-86CA6508C128 Q33390374-58040C6D-1B1F-4EB5-A6D3-D0751BA5DC68 Q33403058-038BF5A6-46DE-4DA8-A201-E1AC5C361ADE Q33541244-30213B27-65FD-46CD-89E3-66BB8724AD63 Q33723337-0CC2E58C-165C-49E0-9988-386ED59A9E04 Q33811371-C8E67DAF-9B33-4B26-A9DA-B2140353C359 Q33813396-4468E55D-21C0-45A6-8BD0-54E144960B00 Q33836863-2221301B-D99A-41E4-B7AA-52F3D93CFD31 Q34166156-06F3B84E-E92E-449C-AFA8-F6C2A59B5A4A Q34235145-87065AA7-985F-46E7-8C77-7935AE71DE7B Q34311476-A4124264-FB88-4B36-B72E-B26588B3B2F2 Q34328049-6F96A567-DECE-4F76-A380-D511F6E61F8E Q34336138-42E74212-84F7-4EA1-9089-21E1AD37A6C6 Q34344856-86CFF694-97FD-47D4-89C7-67D965D3D085 Q34612425-43BFD7BC-7B0A-403E-A323-120BFFE0C584 Q34628967-6C4F4BDB-32A9-401A-8469-997AC7C5A6DF

P2860

Selling sickness: the pharmaceutical industry and disease mongering.

http://www.wikidata.org/entity/Q22242090

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Selling sickness: the pharmaceutical industry and disease mongering

@nl

Selling sickness: the pharmaceutical industry and disease mongering.

@ast

Selling sickness: the pharmaceutical industry and disease mongering.

@en

Selling sickness: the pharmaceutical industry and disease mongering.

@en-gb

type

label

Selling sickness: the pharmaceutical industry and disease mongering

@nl

Selling sickness: the pharmaceutical industry and disease mongering.

@ast

Selling sickness: the pharmaceutical industry and disease mongering.

@en

Selling sickness: the pharmaceutical industry and disease mongering.

@en-gb

prefLabel

Selling sickness: the pharmaceutical industry and disease mongering

@nl

Selling sickness: the pharmaceutical industry and disease mongering.

@ast

Selling sickness: the pharmaceutical industry and disease mongering.

@en

Selling sickness: the pharmaceutical industry and disease mongering.

@en-gb

P1433

Q22242090-E6737778-4EE7-4A29-974E-E54A2089DFEA

P1476

Q22242090-1C56E000-5B11-44FC-98A9-5C880D519699

P2093

Q22242090-3D87D3E0-C403-4379-B82E-A9B062F66829

Q22242090-797AE77C-A40C-4643-BCC0-A4C24436F151

Q22242090-E5A23D2F-1D64-468B-9640-D2882CBA6846

P2860

Q22242090-31514FF9-4F66-4468-B500-ADD37BB8883B

Q22242090-3DA671F0-5F2F-4A84-9E66-0481CC5A2CDE

Q22242090-3FADA521-F9BD-4114-80E7-8CA5747F9799

Q22242090-44245E84-BA6B-4959-BCF2-3F3760F7AC96

Q22242090-44593E7E-3AB5-4BE2-87CA-50431E220C70

Q22242090-669C2A1E-1C4D-4C3C-9AED-5692D880724B

Q22242090-760CC0A3-E072-4B1D-91FF-70FC24A0EC74

Q22242090-7D99F02A-2DFD-4228-8524-4CB9C5F94818

Q22242090-88AAB481-FAC5-49E1-B455-286037596EC5

Q22242090-95FA9084-062A-49C0-B2EC-FE9936392593

P304

Q22242090-9A23AF5B-A7B0-4EB9-B4BF-B55F90F30F6F

P31

Q22242090-8C304D03-1306-4D6F-98BB-4FA78FFE2201

P3181

Q22242090-810928A8-B757-4050-A810-798C0C86696D

P356

Q22242090-B0917097-CFF6-400F-B5AB-F71B8CD3A4EA

P407

Q22242090-743AB7A5-1E6C-4B68-B2A7-CA17C442AD60

P433

Q22242090-9DAE6FDE-B6C2-440B-90D0-DA00BDFC5A54

P478

Q22242090-05E59DE2-15DF-4E3A-B185-FFA40B613006

P577

Q22242090-7DEE332E-BBBF-4488-8171-0F65B65C1AD8

P5875

Q22242090-0FAB0106-E2D8-4C8A-B06B-D927190EB7D9

P698

Q22242090-2CCBE402-0B19-4070-B83C-E612A1F13ECE

P932

Q22242090-90A9BD85-2EC6-4DEE-98EE-27DF77841CAC

P3181

P356

BMJ.324.7342.886

P1433

P1476

Selling sickness: the pharmaceutical industry and disease mongering.

@en

P2093

David Henry

http://www.w3.org/2001/XMLSchema#string

Iona Heath

http://www.w3.org/2001/XMLSchema#string

Ray Moynihan

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for breast cancer with mammography

Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis.

Lifestyle medicines

Rheumatology: 15. Osteoporosis

The impact of informed consent on patient interest in prostate-specific antigen screening.

Changing perceptions in osteoporosis.

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Induced abortion and the risk of breast cancer.

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.

P304

886-891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

623327

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/BMJ.324.7342.886

http://www.w3.org/2001/XMLSchema#string

P407

P433

7342

http://www.w3.org/2001/XMLSchema#string

P478

324

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232262715

http://www.w3.org/2001/XMLSchema#string

P698

11950740

http://www.w3.org/2001/XMLSchema#string

P932

1122833

http://www.w3.org/2001/XMLSchema#string